118 related articles for article (PubMed ID: 6886991)
1. Oral bioavailability and intravenous pharmacokinetics of amrinone in humans.
Park GB; Kershner RP; Angellotti J; Williams RL; Benet LZ; Edelson J
J Pharm Sci; 1983 Jul; 72(7):817-9. PubMed ID: 6886991
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of the bipyridines amrinone and milrinone.
Edelson J; Stroshane R; Benziger DP; Cody R; Benotti J; Hood WB; Chatterjee K; Luczkowec C; Krebs C; Schwartz R
Circulation; 1986 Mar; 73(3 Pt 2):III145-52. PubMed ID: 3510771
[TBL] [Abstract][Full Text] [Related]
3. Amrinone metabolism.
Kullberg MP; Freeman GB; Biddlecome C; Alousi AA; Edelson J
Clin Pharmacol Ther; 1981 Mar; 29(3):394-401. PubMed ID: 7471610
[TBL] [Abstract][Full Text] [Related]
4. Dose proportionality of amrinone.
Edelson J; Park GB; Angellotti J; Kershner RP; Ryan JJ; McMahon FG
Clin Pharmacol Ther; 1983 Aug; 34(2):190-4. PubMed ID: 6872413
[TBL] [Abstract][Full Text] [Related]
5. Oral and intravenous pharmacokinetics of milrinone in human volunteers.
Stroshane RM; Koss RF; Biddlecome CE; Luczkowec C; Edelson J
J Pharm Sci; 1984 Oct; 73(10):1438-41. PubMed ID: 6502494
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic properties of ethosuximide in monkeys. I. Single-dose intravenous and oral administration.
Patel IH; Levy RH; Bauer TG
Epilepsia; 1975 Dec; 16(5):705-16. PubMed ID: 816644
[TBL] [Abstract][Full Text] [Related]
7. Intravenous amrinone for congestive heart failure.
Med Lett Drugs Ther; 1984 Nov; 26(675):104-5. PubMed ID: 6390109
[No Abstract] [Full Text] [Related]
8. Pharmacokinetics of bolus intravenous and oral doses of L-carnitine in healthy subjects.
Harper P; Elwin CE; Cederblad G
Eur J Clin Pharmacol; 1988; 35(1):69-75. PubMed ID: 3220097
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of deramciclane, a novel anxiolytic agent, after intravenous and oral administration.
Huupponen R; Paija O; Salonen M; Björklund H; Rouru J; Anttila M
Drugs R D; 2003; 4(6):339-45. PubMed ID: 14584962
[TBL] [Abstract][Full Text] [Related]
10. Acute pharmacodynamics and pharmacokinetics of oral amrinone.
Benotti JR; Lesko LJ; McCue JE
J Clin Pharmacol; 1982 Oct; 22(10):425-32. PubMed ID: 7174852
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses.
Bergan T; Thorsteinsson SB; Solberg R; Bjornskau L; Kolstad IM; Johnsen S
Am J Med; 1987 Apr; 82(4A):97-102. PubMed ID: 3578334
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration.
Rawlins MD; Henderson DB; Hijab AR
Eur J Clin Pharmacol; 1977 Apr; 11(4):283-6. PubMed ID: 862649
[TBL] [Abstract][Full Text] [Related]
13. Relationship between amrinone plasma concentration and cardiac index.
Edelson J; LeJemtel TH; Alousi AA; Biddlecome CE; Maskin CS; Sonnenblick EH
Clin Pharmacol Ther; 1981 Jun; 29(6):723-8. PubMed ID: 7226703
[TBL] [Abstract][Full Text] [Related]
14. [Experimental and clinical pharmacokinetics of amrinone].
Padrini R; Miglioli PA; Casiglia E; Piovan D; Ferrari M
Cardiologia; 1982; 27(1):103-6. PubMed ID: 6927443
[No Abstract] [Full Text] [Related]
15. Pharmacokinetics of azapropazone following single oral and intravenous doses.
Breuing KH; Gilfrich HJ; Meinertz T; Jähnchen E
Arzneimittelforschung; 1979; 29(6):971-2. PubMed ID: 582795
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic effects of intravenous and oral amrinone in patients with severe heart failure: relationship between intravenous and oral administration.
LeJemtel TH; Keung EC; Schwartz WJ; Maskin CS; Greenberg MA; Davis RS; Forman R; Ribner HS; Sonnenblick EH
Trans Assoc Am Physicians; 1979; 92():325-33. PubMed ID: 549256
[No Abstract] [Full Text] [Related]
17. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and bioavailability of intravenous and intramuscular lorazepam with an adjunct test of the inattention effect in humans.
Nielsen-Kudsk F; Jensen TS; Magnussen I; Jakobsen P; Jensen PB; Mondrup K; Petersen T
Acta Pharmacol Toxicol (Copenh); 1983 Feb; 52(2):121-7. PubMed ID: 6133404
[TBL] [Abstract][Full Text] [Related]
19. 4-Aminopyridine kinetics.
Uges DR; Sohn YJ; Greijdanus B; Scaf AH; Agoston S
Clin Pharmacol Ther; 1982 May; 31(5):587-93. PubMed ID: 7075108
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of intravenous and oral bolus doses of L-carnitine in healthy subjects.
Harper P; Elwin CE; Cederblad G
Eur J Clin Pharmacol; 1988; 35(5):555-62. PubMed ID: 3234464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
